What Researchers Did
Researchers conducted a narrative review to explore the role of hyperbaric oxygen therapy in the treatment of gliomas.
What They Found
They found that gliomas are associated with a high mortality rate and an average survival duration of less than 15 months due to recurrence and resistance to conventional therapies. While hyperbaric oxygen generally showed positive effects on glioma treatment and relieved complications from radiotherapy and chemotherapy, some studies indicated it might promote glioma progression.
What This Means for Canadian Patients
For Canadian patients with gliomas, hyperbaric oxygen therapy may offer potential benefits as an adjuvant treatment to alleviate complications from standard therapies. However, given conflicting evidence suggesting it could also promote tumor progression, its use requires careful consideration and further research.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
As a narrative review, this study may be subject to selection bias and highlights conflicting evidence regarding hyperbaric oxygen's effect on glioma progression.